BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
BCI
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, July 14, 2026
Home
»
Newsletters
» BioWorld
BioWorld
July 26, 2002
View Archived Issues
Acusphere's 7th Round Brings $15M For Porous Microparticles
Read More
Innate Immunity Genetic Pathway Runs Caenorhabditis elegans To Homo sapiens, Tracking Evolution
Read More
Hydra Series A Round: $9.3M To Add To Team, Grow Science
Read More
Other News To Note
Read More
Correction
Read More
Anadys Raises $38.3M In Series C To Advance Hepatitis C Products
Anadys - it's research focus neatly split - raised $38.3 million in its Series C round in what could be its last financing before testing the investment waters with an initial public offering. (BioWorld Today)
Read More
